Pleural effusion

Postgraduate Medical Journal

Volumn 81, Issue 961, 2005, Pages 702-710

  Medford, A ^a   Maskell, N ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; BLEOMYCIN; CARBAPENEM; CEFUROXIME; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; CORTICOSTEROID; DOXYCYCLINE; FIBRINOLYTIC AGENT; GLYCOPROTEIN; MACROLIDE; MESOTHELIN; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SCLEROSING AGENT; STREPTOKINASE; TETRACYCLINE; TRANSFORMING GROWTH FACTOR BETA; UROKINASE; VANCOMYCIN; VASCULOTROPIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBIOTIC THERAPY; ASBESTOSIS; BRONCHOSCOPY; CANCER CYTODIAGNOSIS; CANCER STAGING; CHYLOTHORAX; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISORIENTATION; DRUG FEVER; EMPYEMA; EXUDATE; HEART ARRHYTHMIA; HISTOLOGY; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE DIFFERENTIAL COUNT; META ANALYSIS; PATHOGENESIS; PH; PLEURA BIOPSY; PLEURA DISEASE; PLEURA EFFUSION; PLEURAL PAIN; PLEURECTOMY; PLEURISY; PLEURODESIS; PROTEIN BLOOD LEVEL; PSEUDOCHYLOTHORAX; REVIEW; RHEUMATOID ARTHRITIS; SEPSIS; SURGICAL DRAINAGE; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THORACOCENTESIS; THORACOSCOPY; TREATMENT OUTCOME; TUBE; TUBERCULOUS PLEURISY;

ANTI-BACTERIAL AGENTS; BIOPSY; CATHETERS, INDWELLING; CHEST TUBES; DIAGNOSTIC IMAGING; DRAINAGE; FIBRINOLYTIC AGENTS; HUMANS; MEMBRANE GLYCOPROTEINS; PLEURAL EFFUSION; TRANSFORMING GROWTH FACTOR ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 27844482078     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2005.035352     Document Type: Review

References (108)

1. Chetty KG. Transudative pleural effusions. Clin Chest Med 1985;6:49-54.
2. Light RW. Diagnostic principles in pleural disease. Eur Respir J 1997;10:476-81.
3. Light RW, Erozan YS, Ball WC Jr. Cells in pleural fluid. Their value in differential diagnosis. Arch Intern Med 1973;132:854-60.
4. Light RW, Macgregor MI, Luchsinger PC, et al. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 1972;77:507-13.
5. Ansari T, Idell S. Management of undiagnosed persistent pleural effusions. Clin Chest Med 1998;19:407-17.
6. Light RW, Rogers JT, Cheng D, et al. Large pleural effusions occurring after coronary artery bypass grafting. Ann Intern Med 1999;130:891-6.
7. Hamm H, Light RW. Parapneumonic effusion and empyema. Eur Respir J 1997;10:1150-6.
8. Good JT Jr, Taryle DA, Maulitz RM, et al. The diagnostic value of pleural fluid pH. Chest 1980;78:55-9.
9. Sahn SA, Good JT Jr. Pleural fluid pH in malignant effusions. Diagnostic, prognostic, and therapeutic implications. Ann Intern Med 1988;108:345-9.
10. Renshaw AA, Dean BR, Antman KH, et al. The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Chest 1997;111:106-9.
11. Prakash UB, Reiman HM. Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases. Mayo Clin Proc 1985;60:158-64.
12. Garcia LW, Ducatman BS, Wang HH. The value of multiple fluid specimens in the cytological diagnosis of malignancy. Mod Pathol 1994;7:665-8.
13. Dekker A, Bupp PA. Cytology of serous effusions. An investigation into the usefulness of cell blocks versus smears. Am J Clin Pathol 1978;70:855-60.
14. Brown RW, Clark GM, Tandon AK, et al. Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma. Hum Pathol 1993;24:347-54.
15. Blackmore CC, Black WC, Dallas RV, et al. Pleural fluid volume estimation: a chest radiograph prediction rule. Acad Radiol 1996;3:103-9.
16. Ruskin JA, Gurney JW, Thorsen MK, et al. Detection of pleural effusions on supine chest radiographs. AJR Am J Roentgenol 1987;148:681-3.
17. Eibenberger KL, Dock WI, Ammann ME, et al. Quantification of pleural effusions: sonography versus radiography. Radiology 1994;191:681-4.
18. Yang PC, Luh KT, Chang DB, et al. Value of sonography in determining the nature of pleural effusion: analysis of 320 cases. Am J Roentgenol 1992;159:29-33.
19. Leung AN, Muller NL, Miller RR. CT in differential diagnosis of diffuse pleural disease. Am J Roentgenol 1990;154:487-92.
20. Traill ZC, Davies RJ, Gleeson FV. Thoracic computed tomography in patients with suspected malignant pleural effusions. Clin Radiol 2001;56:193-6.
21. Boutin C, Rey F, Viallat JR. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest 1995;108:754-8.
22. Hirsch A, Ruffie P, Nebut M, et al. Pleural effusion: laboratory tests in 300 cases. Thorax 1979;34:106-12.
23. Mungall IP, Cowen PN, Cooke NT, et al. Multiple pleural biopsy with the Abrams needle. Thorax 1980;35:600-2.
24. Tomlinson JR. Invasive procedures in the diagnosis of pleural disease. Semin Respir Med 1987;9:30-6.
25. Maskell NA, Gleeson FV, Davies RJ. Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial. Lancet 2003;361:1326-30.
26. Adams RF, Gray W, Davies RJ, et al. Percutaneous image-guided cutting needle biopsy of the pleura in the diagnosis of malignant mesothelioma. Chest 2001;120:1798-802.
27. Loddenkemper R. Thoracoscopy - state of the art. Eur Respir J 1998;11:213-21.
28. Mallawathantri S, Lim WS, Kinnear W. Setting up a medical thoracoscopy service: safety and efficacy. Thorax 2004;59(suppl II):ii40-41.
29. Chang SC, Perng RP. The role of fiberoptic bronchoscopy in evaluating the causes of pleural effusions. Arch Intern Med 1989;149:855-7.
30. Idell S. Evaluation of perplexing pleural effusions. Contemp Intern Med 1994;6:31-9.
31. Burgess U, Maritz FJ, Le R, et al. Use of adenosine deaminase as a diagnostic tool for tuberculous pleurisy. Thorax 1995;50:672-4.
32. Turton CW. Troublesome pleural fluid. Br J Dis Chest 1987;81:217-24.
33. Hillerdal G. Chylothorax and pseudochylothorax. Eur Respir J 1997;10:1157-62.
34. Pettersson T, Klockars M, Hellstrom PE. Chemical and immunological features of pleural effusions: comparison between rheumatoid arthritis and other diseases. Thorax 1982;37:354-61.
35. Joseph J, Sahn SA. Connective tissue diseases and the pleura. Chest 1993;104:262-70.
36. Khare V, Baethge B, Lang S, et al. Antinuclear antibodies in pleural fluid. Chest 1994;106:866-71.
37. Afessa B. Pleural effusions and pneumothoraces in AIDS. Curr Opin Pulm Med 2001;7:202-9.
38. Afessa B. Pleural effusion and pneumothorax in hospitalized patients with HIV infection: the pulmonary complications, ICU support, and prognostic factors of hospitalized patients with HIV (PIP) study. Chest 2000;117:1031-7.
39. Epler GR, McLoud TC, Gaensler EA. Prevalence and incidence of benign asbestos pleural effusion in a working population. JAMA 1982;247:617-22.
40. Hillerdal G, Ozesmi M. Benign asbestos pleural effusion: 73 exudates in 60 patients. Eur J Respir Dis 1987;71:113-21.
41. Morelock SY, Sahn SA. Drugs and the pleura. Chest 1999;116:212-21.
42. Good JT Jr, King TE, Antony VB, et al. Lupus pleuritis. Clinical features and pleural fluid characteristics with special reference to pleural fluid antinuclear antibodies. Chest 1983;84:714-18.
43. Yung RL, Johnson KJ, Richardson BC. New concepts in the pathogenesis of drug-induced lupus. Lab Invest 1995;73:746-59.
44. Chernow B, Sahn SA. Carcinomatous involvement of the pleura: an analysis of 96 patients. Am J Med 1977;63:695-702.
45. DiBonito L, Falconieri G, Colautti I, et al. The positive pleural effusion. A retrospective study of cytopathologic diagnoses with autopsy confirmation. Acta Cytol 1992;36:329-32.
46. Negrini D, Pistolesi M, Miniati M, et al. Regional protein absorption rates from the pleural cavity in dogs. J Appl Physiol 1985;58:2062-7.
47. Kraft A, Weindel K, Ochs A, et al. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer 1999;85:178-87.
48. Ferrara N, Gerber HP, Lecouter J. The biology of VEGF and its receptors. Nat Med 2003;9:669-76.
49. Maher GG, Berger HW. Massive pleural effusion: malignant and nonmalignant causes in 46 patients. Am Rev Respir Dis 1972;105:458-60.
50. Sorensen PG, Svendsen TL, Enk B. Treatment of malignant pleural effusion with drainage, with and without instillation of talc. Eur J Respir Dis 1984;65:131-5.
51. Antony VB. Pathogenesis of malignant pleural effusions and talc pleurodesis. Pneumologie 1999;53:493-8.
52. Xie C, Teixeira LR, McGovern JP, et al. Systemic corticosteroids decrease the effectiveness of talc pleurodesis. Am J Respir Crit Care Med 1998;157:1441-4.
53. Parker LA, Charnock GC, Delany DJ. Small bore catheter drainage and sclerotherapy for malignant pleural effusions. Cancer 1989;64:1218-21.
54. Clementsen P, Evald T, Grode G, et al. Treatment of malignant pleural effusion: pleurodesis using a small percutaneous catheter. A prospective randomized study. Respir Med 1998;92:593-6.
55. Villanueva AG, Gray AW Jr, Shahian DM, et al. Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions. Thorax 1994;49:23-5.
56. Tarver RD, Broderick LS, Conces DJ Jr. Reexpansion pulmonary edema. J Thorac Imaging 1996;11:198-209.
57. Pulsiripunya C, Youngchaiyud P, Pushpakom R, et al. The efficacy of doxycycline as a pleural sclerosing agent in malignant pleural effusion: a prospective study. Respirology 1996;1:69-72.
58. Wooten SA, Barbarash RA, Strange C, et al. Systemic absorption of tetracycline and lidocaine following intrapleural instillation. Chest 1988;94:960-3.
59. Sherman S, Grady KJ, Seidman JC. Clinical experience with tetracycline pleurodesis of malignant pleural effusions. South Med J 1987;80:716-19.
60. Kennedy L, Rusch VW, Strange C, et al. Pleurodesis using talc slurry. Chest 1994;106:342-6.
61. Yim AP, Chung SS, Lee TW, et al. Thoracoscopic management of malignant pleural effusions. Chest 1996;109:1234-8.
62. Zimmer PW, Hill M, Casey K, et al. Prospective randomized trial of talc slurry vs bleomycin in pleurodesis for symptomatic malignant pleural effusions. Chest 1997;112:430-4.
63. Maskell NA, Lee YC, Gleeson FV, et al. Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size. Am J Respir Crit Care Med 2004;170:377-82.
64. Kessinger A, Wigton RS. Intracavitary bleomycin and tetracycline in the management of malignant pleural effusions: a randomized study. J Surg Oncol 1987;36:81-3.
65. Evans TR, Stein RC, Pepper JR, et al. A randomised prospective trial of surgical against medical tetracycline pleurodesis in the management of malignant pleural effusions secondary to breast cancer Eur J Cancer 1993;29A:316-19.
66. McAlpine L, Kay J, Thomson N. Tetracycline pleurodesis in malignant pleural effusion: a comparison of needle aspiration with intercostal tube drainage. Thorax 1995;50:437P.
67. Dryzer SR, Allen ML, Strange C, et al. A comparison of rotation and nonrotation in tetracycline pleurodesis. Chest 1993;104:1763-6.
68. Jerjes-Sanchez C, Ramirez-Rivera A, Elizalde JJ, et al. Intrapleural fibrinolysis with streptokinase as an adjunctive treatment in hemothorax and empyema: a multicenter trial. Chest 1996;109:1514-19.
69. Davies CW, Traill ZC, Gleeson FV, et al. Intrapleural streptokinase in the management of malignant multiloculated pleural effusions. Chest 1999;115:729-33.
70. Gilkeson RC, Silverman P, Haaga JR. Using urokinase to treat malignant pleural effusions. Am J Roentgenol 1999;173:781-3.
71. Putnam JB Jr, Walsh GL, Swisher SG, et al. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg 2000;69:369-75.
72. Fry WA, Khandekar JD. Parietal pleurectomy for malignant pleural effusion. Ann Surg Oncol 1995;2:160-4.
73. Waller DA, Morritt GN, Forty J. Video-assisted thoracoscopic pleurectomy in the management of malignant pleural effusion. Chest 1995;107:1454-6.
74. Lee KA, Harvey JC, Reich H, et al. Management of malignant pleural effusions with pleuroperitoneal shunting. J Am Coll Surg 1994;178:586-8.
75. Peters RM. Empyema thoracis: historical perspective. Ann Thorac Surg 1989;48:306-8.
76. Light RW, Girard WM, Jenkinson SG, et al. Parapneumonic effusions. Am J Med 1980;69:507-12.
77. Kroegel C, Antony VB. Immunobiology of pleural inflammation: potential implications for pathogenesis, diagnosis and therapy. Eur Respir J 1997;10:2411-18.
78. Storm HK, Krasnik M, Bang K, et al. Treatment of pleural empyema secondary to pneumonia: tnoracocentesis regimen versus tube drainage. Thorax 1992;47:821-4.
79. Ashbaugh DG. Empyema thoracis. Factors influencing morbidity and mortality. Chest 1991;99:1162-5.
80. Kearney SE, Davies CW, Davies RJ, et al. Computed tomography and ultrasound in parapneumonic effusions and empyema. Clin Radiol 2000;55:542-7.
81. Multer NL. Imaging of the pleura. Radiology 1993;186:297-309.
82. Aquino SL, Webb WR, Gushiken BJ. Pleural exudates and transudates: diagnosis with contrast-enhanced CT. Radiology 1994;192:803-8.
83. Cham CW, Haq SM, Rahamim J. Empyema thoracis: a problem with late referral? Thorax 1993;48:925-7.
84. Davies CW, Kearney SE, Gleeson FV, et al. Predictors of outcome and long-term survival in patients with pleural infection. Am J Respir Crit Care Med 1999;160:1682-7.
85. Heffner JE, Brown LK, Barbieri C, et al. Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis. Am J Respir Crit Care Med 1995;151:1700-8.
86. Lesho EP, Roth BJ. Is pH paper an acceptable, low-cost alternative to the blood gas analyzer for determining pleural fluid pH? Chest 1997;112:1291-2.
87. Maskell NA, Gleeson FV, Darby M, et al. Diagnostically significant variations in pleural fluid pH in loculated parapneumonic effusions. Chest 2004;126:2022-4.
88. Huang HC, Chang HY, Chen CW, et al. Predicting factors for outcome of tube thoracostomy in complicated parapneumonic effusion for empyema. Chest 1999;115:751-6.
89. Silverman SG, Mueller PR, Saini S, et al. Thoracic empyema: management with image-guided catheter drainage. Radiology 1988;169:5-9.
90. Miller KS, Sahn SA. Chest tubes. Indications, technique, management and complications. Chest 1987;91:258-64.
91. Bartlett JG. Antibiotics in lung abscess. Semin Respir Infect 1991;6:103-11.
92. Hughes CE, Van Scoy RE. Antibiotic therapy of pleural empyema. Semin Respir Infect 1991;6:94-102.
93. Neild JE, Eykyn SJ, Phillips I. Lung abscess and empyema. Q J Med 1985;57:875-82.
94. Tillelt W, Sherry S. The effect in patients of streptococcal fibrinolysin (streptokinase) and streptococcal deoxyribonuclease on fibrinous, purulent and sanguinous pleural exudations. J Clin Invest 1949;28:173-90.
95. Davies RJ, Traill ZC, Gleeson FV. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax 1997;52:416-21.
96. Bouros D, Schiza S, Tzanakis N, et al. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study. Am J Respir Crit Care Med 1999;159:37-42.
97. Bilaceroglu S, Cagercli U, Cakan A. Management of complicated parapneumonic pleural effusions with image-guided drainage and intrapleural urokinase or streptokinase: a controlled randomized trial. Eur Respir J 1997;10:325S.
98. Thomson AH, Hull J, Kumar MR, et al. Randomised trial of intrapleural urokinase in the treatment of childhood empyema. Thorax 2002;57:343-7.
99. Berglin E, Ekroth R, Teger-Nilsson AC, et al. Intrapleural instillation of streptokinase. Effects on systemic fibrinolysis. Thorac Cardiovasc Surg 1981;29:124-6.
100. Davies CW, Lok S, Davies RJ. The systemic fibrinolytic activity of intrapleural streptokinase. Am J Respir Crit Care Med 1998;157:328-30.
101. Light RW, Nguyen T, Mulligan ME, et al. The in vitro efficacy of varidase versus streptokinase or urokinase for liquefying thick purulent exudative material from loculated empyema. Lung 2000;178:13-18.
102. Maskell NA, Davies CW, Nunn AJ, et al. UK Controlled trial of intrapleural streptokinase for pleura infection. N Engl J Med 2005;352:926-8.
103. Naidich DP, Lee JJ, Garay SM, et al. Comparison of CT and fiberoptic bronchoscopy in the evaluation of bronchial disease. Am J Roentgenol 1987;148:1-7.
104. Robinson BW, Creaney J, Lake R, et al. Mesothelin-family proteins and diagnosis of mesothelioma. Lancet 2003;362:1612-16.
105. Lee YC, Yasay JR, Johnson JE, et al. Comparing transforming growth factor-beta2, talc and bleomycin as pleurodesing agents in sheep. Respirology 2002;7:209-16.
106. Lee YC, Lane KB, Zoia O, et al. Transforming growth factor-beta induces collagen synthesis without inducing IL-8 production in mesothelial cells. Eur Respir J 2003;22:197-202.
107. Grove CS, Lee YC. Vascular endothelial growth factor: the key mediator in pleural effusion formation. Curr Opin Pulm Med 2002;8:294-301.
108. Maskell NA, Davies CWH, Ghabe R, et al. Predictors of survival in patients with pleural infection but without cancer: results from the MRC/BTS MIST trial, ICTN 39138989. Thorax 2004;59(suppl II):ii40.